Roscoe D E, Holste W C, Sorhage F E, Campbell C, Niezgoda M, Buchannan R, Diehl D, Niu H S, Rupprecht C E
New Jersey Division of Fish, Game and Wildlife, Trenton 08625-0400, USA.
J Wildl Dis. 1998 Oct;34(4):752-63. doi: 10.7589/0090-3558-34.4.752.
A field trial to evaluate the efficacy of an oral vaccinia-rabies glycoprotein recombinant virus vaccine in controlling epidemic raccoon (Procyon lotor) rabies was conducted by distributing 180,816 doses (10(8.2)TCID50/ml) of vaccine in wax ampules within fish-meal polymer baits at a rate of 64 doses/km2/treatment throughout a 552 km2 area, forming an 18 km wide band across the northern Cape May Peninsula of New Jersey (USA). Vaccination treatments were conducted in the spring and fall between May 1992 and October 1994 from a helicopter along ecotones and from motor vehicles along roads. Vaccine-laden baits were removed by animals from tracking stations within 3 wk and 61% of the identifiable tracks were those of raccoons. Tetracycline incorporated in the baits as a biomarker was detected in 155 (73%) of the vaccination area raccoons following the fall 1993 and spring 1994 vaccinations. Eleven (61%) of the raccoons sampled in the same time period seroconverted (> or = 0.5 IU) in response to rabies virus glycoprotein. A raccoon diagnosed with rabies from the northern border of the vaccination area on 30 April 1993 provided the first evidence that the barrier was being challenged by the rabies epidemic. The prevalence of rabies in raccoons from the vaccination area for the first year (10%, n = 96) and second year (8%, n = 61) of challenge was reduced more than six-fold by vaccination compared to unvaccinated raccoons from northern adjacent surveillance areas during the corresponding first (65%, n = 189) and second years (53%, n = 43). Vaccination also effectively reduced by three-fold the rate at which the epidemic moved through the raccoon population (15 km/yr). The breach of the vaccination area resulted in a resumption of the high rate (43 km/yr) of epidemic movement and a significant nine-fold increase in rabies prevalence (77%, n = 47). The maximum linear movement (12.9 km) among five ear-tagged rabid raccoons in the study area was significantly greater than that of 19 normal radio-collared raccoons (2.58 km) in the area. These large movements of rabid raccoons, together with relocation of nuisance raccoons, spillover of raccoon rabies in skunks (Mephitis mephitis) and other species, insufficient funding and a decision to discontinue the program in 1994 (which could have resulted in insufficient population immunity among raccoons in the vaccination area) may have contributed to the eventual breach of the barrier.
开展了一项田间试验,以评估口服痘苗 - 狂犬病糖蛋白重组病毒疫苗在控制浣熊(北美浣熊)狂犬病流行方面的效果。在鱼粉聚合物诱饵的蜡封安瓿中分发了180,816剂疫苗(10(8.2) TCID50/ml),在整个552平方公里的区域内以每平方公里64剂的剂量进行处理,在美国新泽西州梅角半岛北部形成了一条18公里宽的带。1992年5月至1994年10月期间的春季和秋季,从直升机沿着生态交错带以及从机动车沿着道路进行疫苗接种处理。携带疫苗的诱饵在3周内被动物从追踪站取走,61%可识别的踪迹是浣熊的。在1993年秋季和1994年春季接种疫苗后,在接种区域的155只(73%)浣熊中检测到作为生物标志物掺入诱饵中的四环素。在同一时期采样的11只(61%)浣熊因狂犬病病毒糖蛋白而血清转化(≥0.5 IU)。1993年4月30日在接种区域北部边界诊断出一只患有狂犬病的浣熊,这首次证明狂犬病疫情正在对该屏障构成挑战。与来自北部相邻监测区域未接种疫苗的浣熊在相应的第一年(65%,n = 189)和第二年(53%,n = 43)相比,接种区域浣熊在受挑战的第一年(10%,n = 96)和第二年(8%,n = 61)的狂犬病患病率因接种疫苗而降低了六倍多。接种疫苗还有效地将疫情在浣熊种群中传播的速度降低了三倍(每年15公里)。接种区域出现缺口导致疫情传播速度恢复到高速度(每年43公里),狂犬病患病率显著增加了九倍(77%,n = 47)。研究区域内五只带有耳标的狂犬病浣熊的最大直线移动距离(12.9公里)明显大于该区域内19只正常佩戴无线电项圈的浣熊(2.58公里)。狂犬病浣熊的这些大移动,加上讨厌的浣熊的迁移、浣熊狂犬病在臭鼬(臭鼬属)和其他物种中的溢出、资金不足以及1994年决定停止该项目(这可能导致接种区域浣熊群体免疫力不足),可能促成了最终屏障的突破。